Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
about
Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseasesOverproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexesMEK1 inactivates Myt1 to regulate Golgi membrane fragmentation and mitotic entry in mammalian cellsThe decision to enter mitosis: feedback and redundancy in the mitotic entry networkM-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCPThe p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinaseThe essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteinsUltrasensitivity in the Regulation of Cdc25C by Cdk1Mechanisms of G2 arrest in response to overexpression of p53Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognitionCdc25B and Cdc25C differ markedly in their properties as initiators of mitosisSmall non-coding RNAs govern mammary gland tumorigenesisFeedback loops and reciprocal regulation: recurring motifs in the systems biology of the cell cycleGenome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like CellsCell cycle checkpoint in cancer: a therapeutically targetable double-edged swordThe Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stabilityForkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivatorsA bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export.Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibitedInhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit.Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione.Altered regulation of cell cycle machinery involved in interleukin-1-induced G(1) and G(2) phase growth arrest of A375S2 human melanoma cells.Spermatogenesis-defective (spe) mutants of the nematode Caenorhabditis elegans provide clues to solve the puzzle of male germline functions during reproduction.Cell cycle control, checkpoint mechanisms, and genotoxic stress.Molecular interaction map of the mammalian cell cycle control and DNA repair systems.Four-dimensional control of the cell cycle.The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.WEE2 is an oocyte-specific meiosis inhibitor in rhesus macaque monkeys.The Polo-like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs.Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint.Triggering the all-or-nothing switch into mitosis.Anticancer effects of CKD-602 (Camtobell(®)) via G2/M phase arrest in oral squamous cell carcinoma cell linesEctopic expression of the Drosophila Cdk1 inhibitory kinases, Wee1 and Myt1, interferes with the second mitotic wave and disrupts pattern formation during eye development.Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.The role of the LH subdomain in the function of the Cip/Kip cyclin-dependent kinase regulators.Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells
P2860
Q21245705-E91F51CA-9636-4DEC-A1AD-A9568963888BQ22010138-A744DA1B-52EC-4169-BB17-7060FE72FEE0Q24306189-29898A8C-3758-45C3-8A70-C946FB38F4D3Q24315132-33C98E2D-786F-4FEB-A315-E0C928B4832EQ24329203-268E64DC-26DD-457E-987A-684C46A84E96Q24553550-837C0A14-F091-4671-A40B-4164B58B2993Q24606249-9D25CE30-B405-4CA8-9756-CF84A8150425Q24633843-BC1A6960-B217-4BFE-A6E3-392AF49C1068Q24654806-F7B59D2B-42DD-476A-9B6F-D8CAFDBFC1A7Q24671639-43CDD019-923C-4095-B450-6EEFE8329A10Q24685826-36855725-990C-4899-BB67-28A417DE5F08Q27007057-B39927C8-E556-423D-9957-880799E31E57Q27021741-43F14FD3-26A1-4F34-B9E2-6BAAC261A789Q27320024-D335BB1E-A3A8-4A74-B0D1-4C57DE18ECA1Q28078268-0A1F6451-FC19-4960-911C-A123AE113CC5Q28145108-BD3F86C2-8D9E-4B69-BDC7-8DD6CC466D77Q28612074-4D8B8DC7-FC53-48DB-A910-6F7A33D87F71Q28612153-8E545AC5-B9D8-4296-A87F-D51CB2901819Q30492543-9DC1E8CA-DFE6-4E10-9672-A6BD72F5BE16Q30499682-4D03E9B7-17B3-43EF-B8DD-B86956C8CF6AQ30502423-77313BF8-5E6D-495C-9D9F-9B8270670DC7Q30858270-633CBBF1-9052-49CB-AD01-FACFCADA4D91Q31633427-6F27216F-8CB8-46A5-86A6-BACB76FF4862Q33348988-85E922D1-2841-4A9C-9CDF-086C93023FD8Q33608768-9F4F031F-F0F2-46A6-889A-71B88014ED30Q33704559-2D3228DD-3E38-4DCB-9B55-EC4C9637E10DQ33772655-B8F3D768-B69F-4DAB-B0D0-0CD37DF2C4A0Q33794196-BE8D0A91-CE92-4E46-9705-CA104E601B0AQ33868857-3E39178D-FD4E-4239-9E50-1E59A4D7BA9FQ33930739-6AFC4796-E54D-48FC-99FB-6301E96C3EA9Q34195806-7547CF5A-1EEE-490D-A760-EEDF877CAD1AQ34221455-AD1E7D13-39EC-4431-960F-8C3F45D14E11Q34236659-1EEACF6C-0154-4157-BDA1-D1AED3765709Q34410978-66ED4F9F-639C-40C3-B90F-07CA9DE6C2FAQ34446333-EE2C006A-385D-4505-A923-FA2E97284AD2Q34582478-599A9F54-D417-4675-B44E-93DB88C3D46EQ34615365-926BC016-6E74-42EC-B2CE-0621ECC80666Q34869625-9A0B21D1-DC62-47BF-95AB-944375DB37C6Q34978182-FFE6D20A-8932-4B95-9651-3A540CB21027Q35002896-CA07AC94-33C0-4211-89B8-BD34E3A80708
P2860
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@ast
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en-gb
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@nl
type
label
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@ast
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en-gb
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@nl
prefLabel
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@ast
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en-gb
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@nl
P2093
P3181
P356
P1476
Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity
@en
P2093
P304
P3181
P356
10.1074/JBC.272.35.22300
P407
P577
1997-08-29T00:00:00Z